Novartis’ blood pressure drug Exforge receives tentative FDA approval
The treatment is expected to be available in the US in late September, 2007, pending the expiration of market exclusivity and patent protection for amlodipine besylate.
 |
 |
 |
 |
Novartis’ blood pressure drug Exforge receives tentative FDA approval
The treatment is expected to be available in the US in late September, 2007, pending the expiration of market exclusivity and patent protection for amlodipine besylate.
|
|
|
|